Document is current
Any future updates will be listed below
-
Authors
Mestre-Ferrandiz, Jorge
Palaska, Christina http://orcid.org/0000-0001-7056-1792
Kelly, Tom
Hutchings, Adam
Parnaby, Adam
-
Funding
Funding for this research was provided by:
Celgene Corporation
- License Information
-
More Information
Article History
Received: 26 April 2019
Accepted: 29 October 2019
First Online: 11 December 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: JMF, CP, TK and AH have performed paid consultancy services for Celgene. CP, TK and AH also provide paid consultancy services to other pharmaceutical companies, some of whom manufacture medicines for rare disease. AP is a Celgene employee.
